Literature DB >> 25155244

Debate: A bridge too far--liver transplantation for nonalcoholic steatohepatitis will overwhelm the organ supply.

Julie Heimbach1.   

Abstract

The obesity epidemic is one of the greatest health challenges currently facing the general population, and it will have a major impact on LT because of the associated rise in the incidence of NASH and NASH-related HCC. There is already a severe shortage of available liver allografts, which will be exacerbated by an increased demand for LT with the rising incidence of obesity-related liver disease. Because the obesity crisis also impacts the availability of suitable living and deceased organ donors, the impact will be far more significant. Research and public health initiatives aimed at further elucidating and counteracting obesity in both adults and especially children is paramount.

Entities:  

Mesh:

Year:  2014        PMID: 25155244     DOI: 10.1002/lt.23980

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  8 in total

1.  Suboptimal Use of Inpatient Palliative Care Consultation May Lead to Higher Readmissions and Costs in End-Stage Liver Disease.

Authors:  Adeyinka Charles Adejumo; Donghee Kim; Umair Iqbal; Eric R Yoo; Brian C Boursiquot; George Cholankeril; Robert J Wong; Paul Y Kwo; Aijaz Ahmed
Journal:  J Palliat Med       Date:  2019-08-09       Impact factor: 2.947

2.  The Role of Neuregulin-1 in Steatotic and Non-Steatotic Liver Transplantation from Brain-Dead Donors.

Authors:  Marc Micó-Carnero; Araní Casillas-Ramírez; Alfredo Sánchez-González; Carlos Rojano-Alfonso; Carmen Peralta
Journal:  Biomedicines       Date:  2022-04-23

Review 3.  Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease.

Authors:  Donald B Jump; Kelli A Lytle; Christopher M Depner; Sasmita Tripathy
Journal:  Pharmacol Ther       Date:  2017-07-16       Impact factor: 12.310

4.  Prognostic Value of Non-Invasive Fibrosis and Steatosis Tools, Hepatic Venous Pressure Gradient (HVPG) and Histology in Nonalcoholic Steatohepatitis.

Authors:  Giada Sebastiani; Rasha Alshaalan; Philip Wong; Maria Rubino; Ayat Salman; Peter Metrakos; Marc Deschenes; Peter Ghali
Journal:  PLoS One       Date:  2015-06-17       Impact factor: 3.240

5.  Alcoholic vs non-alcoholic fatty liver in rats: distinct differences in endocytosis and vesicle trafficking despite similar pathology.

Authors:  Karuna Rasineni; Daniel D Penrice; Sathish Kumar Natarajan; Mark A McNiven; Benita L McVicker; Kusum K Kharbanda; Carol A Casey; Edward N Harris
Journal:  BMC Gastroenterol       Date:  2016-02-29       Impact factor: 3.067

Review 6.  Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?

Authors:  Ivana Mikolasevic; Tajana Filipec-Kanizaj; Maja Mijic; Ivan Jakopcic; Sandra Milic; Irena Hrstic; Nikola Sobocan; Davor Stimac; Patrizia Burra
Journal:  World J Gastroenterol       Date:  2018-04-14       Impact factor: 5.742

7.  Influence of Genistein on Hepatic Lipid Metabolism in an In Vitro Model of Hepatic Steatosis.

Authors:  Lena Seidemann; Anne Krüger; Victoria Kegel-Hübner; Daniel Seehofer; Georg Damm
Journal:  Molecules       Date:  2021-02-22       Impact factor: 4.411

8.  Prevalence and predictors of nonalcoholic fatty liver disease in South Asian women with polycystic ovary syndrome.

Authors:  Mohamed Shengir; Srinivasan Krishnamurthy; Peter Ghali; Marc Deschenes; Philip Wong; Tianyan Chen; Giada Sebastiani
Journal:  World J Gastroenterol       Date:  2020-11-28       Impact factor: 5.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.